Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)

Editor

Personal info

View

About

Terms

Javascript disabled

Please enable Javascript support in your browser to use this application.

Instructions on how to enable JavaScript on different browsers can be found here: http://www.google.com/support/bin/answer.py?answer=23852.

Sue J. Goldie

Department of Health Policy and Management

Program in Health Decision Science

Harvard School of Public Health

718 Huntington Avenue

United States of America

[email]@*.harvard.edu

Name/email consistency: high

[Claim this account]

Affiliations

Department of Health Policy and Management, Program in Health Decision Science, Harvard School of Public Health, 718 Huntington Avenue, United States of America. 2007
Center for Risk Analysis, Department of Health Policy and Management, Harvard University School of Public Health, Boston, USA. 1999 - 2004
Department of Health Policy and Management, Harvard Center for Risk Analysis, 718 Huntington Avenue, 2nd Floor, USA. 2003
Center for Risk Analysis, Harvard School of Public Health, Boston, Massachusetts 02115-5924, USA. 2003

References

Cost-effectiveness of HPV 16, 18 vaccination in Brazil. Goldie, S.J., Kim, J.J., Kobus, K., Goldhaber-Fiebert, J.D., Salomon, J., O'shea, M.K., Xavier Bosch, F., de Sanjosé, S., Franco, E.L. Vaccine (2007) [Pubmed]
Cost-effectiveness of human papillomavirus DNA testing for cervical cancer screening in women aged 30 years or more. Goldie, S.J., Kim, J.J., Wright, T.C. Obstet. Gynecol (2004) [Pubmed]
Projected clinical benefits and cost-effectiveness of a human papillomavirus 16/18 vaccine. Goldie, S.J., Kohli, M., Grima, D., Weinstein, M.C., Wright, T.C., Bosch, F.X., Franco, E. J. Natl. Cancer Inst. (2004) [Pubmed]
Chapter 15: Public health policy and cost-effectiveness analysis. Goldie, S.J. J. Natl. Cancer Inst. Monographs (2003) [Pubmed]
A potential error in evaluating cancer screening: a comparison of 2 approaches for modeling underlying disease progression. Goldie, S.J., Kuntz, K.M. Med. Decis. Making (2003) [Pubmed]
A refined estimate of the average lifetime cost of pelvic inflammatory disease. Yeh, J.M., Hook, E.W., Goldie, S.J. Sex. Transm. Dis (2003) [Pubmed]
A comprehensive natural history model of HPV infection and cervical cancer to estimate the clinical impact of a prophylactic HPV-16/18 vaccine. Goldie, S.J., Grima, D., Kohli, M., Wright, T.C., Weinstein, M., Franco, E. Int. J. Cancer (2003) [Pubmed]
Projecting the cost-effectiveness of adherence interventions in persons with human immunodeficiency virus infection. Goldie, S.J., Paltiel, A.D., Weinstein, M.C., Losina, E., Seage, G.R., Kimmel, A.D., Walensky, R.P., Sax, P.E., Freedberg, K.A. Am. J. Med. (2003) [Pubmed]
Health economics and cervical cancer prevention: a global perspective. Goldie, S.J. Virus Res. (2002) [Pubmed]
Policy analysis of cervical cancer screening strategies in low-resource settings: clinical benefits and cost-effectiveness. Goldie, S.J., Kuhn, L., Denny, L., Pollack, A., Wright, T.C. JAMA (2001) [Pubmed]
The costs, clinical benefits, and cost-effectiveness of screening for cervical cancer in HIV-infected women. Goldie, S.J., Weinstein, M.C., Kuntz, K.M., Freedberg, K.A. Ann. Intern. Med. (1999) [Pubmed]
The clinical effectiveness and cost-effectiveness of screening for anal squamous intraepithelial lesions in homosexual and bisexual HIV-positive men. Goldie, S.J., Kuntz, K.M., Weinstein, M.C., Freedberg, K.A., Welton, M.L., Palefsky, J.M. JAMA (1999) [Pubmed]

The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.